This is copied from the email update of June 26
Post# of 9122
Posted On: 09/15/2015 9:53:20 PM
Re: beachlover12 #1926
This is copied from the email update of June 26
"The researchers in Houston anticipate the final confirmation testing against antibiotics to be complete within a few weeks, predicated upon no problems with the quality and available quantity of vendor-supplied antibodies for the final bacteria in their test. Following that completion, the results of the research will be submitted to a peer-reviewed journal for publication. After that submittal has been completed, and prior to publication, a sensitivity confirmation study will be done by MDs and researchers who, in order to maintain objectivity in their research, were not part of the N-Assay development research. That study will be a relatively short study of potentially a month or two, and is essential for acceptance of the N-Assay for use as a diagnostic."
It looked self explanatory, but perhaps my perception is faulty.
Regardless,
I called NanoLogix last week and was told that there have been two bad batches of antibodies delivered in July and August and they didn't provide the results they'd seen with the earlier batch in June. When I asked about updating in an email I was told that it would be seen as making excuses for something that was beyond the company's control and there would be no update until the work was completed with viable antibodies that have been obtained from another supplier. It was volunteered that at times antibodies used on other tests in the past had to be replaced because they were old or denatured.
It seems the email update already covered the potential, which apparently was stated because it had occurred before. Don't make an issue out of nothing and dredge up the bs about "stated deadlines" when there were none stated.
S
"The researchers in Houston anticipate the final confirmation testing against antibiotics to be complete within a few weeks, predicated upon no problems with the quality and available quantity of vendor-supplied antibodies for the final bacteria in their test. Following that completion, the results of the research will be submitted to a peer-reviewed journal for publication. After that submittal has been completed, and prior to publication, a sensitivity confirmation study will be done by MDs and researchers who, in order to maintain objectivity in their research, were not part of the N-Assay development research. That study will be a relatively short study of potentially a month or two, and is essential for acceptance of the N-Assay for use as a diagnostic."
It looked self explanatory, but perhaps my perception is faulty.
Regardless,
I called NanoLogix last week and was told that there have been two bad batches of antibodies delivered in July and August and they didn't provide the results they'd seen with the earlier batch in June. When I asked about updating in an email I was told that it would be seen as making excuses for something that was beyond the company's control and there would be no update until the work was completed with viable antibodies that have been obtained from another supplier. It was volunteered that at times antibodies used on other tests in the past had to be replaced because they were old or denatured.
It seems the email update already covered the potential, which apparently was stated because it had occurred before. Don't make an issue out of nothing and dredge up the bs about "stated deadlines" when there were none stated.
S
(0)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼